Division of Burn, Trauma, Acute and Critical Care, UTSouthwestern Medical Center, Parkland Hospital, Dallas, Texas.
UTSouthwestern Medical School, Dallas, Texas.
J Surg Res. 2021 Jul;263:124-129. doi: 10.1016/j.jss.2021.01.020. Epub 2021 Feb 27.
Current guidelines for severe rib fractures recommend neuraxial blockade in addition to multimodal pain therapies. While the guidelines for venous thromboembolism prevention recommend chemoprophylaxis, these medications must be held for neuraxial blockade placement. Erector spinae plane block (ESPB) is a newly described block for thoracic pain control. Advantages include its quick learning curve and potential for less bleeding complications. We describe the use of ESPB for rib fractures in patients on chemoprophylaxis. We hypothesize that ESPB can be performed in this patient population without holding chemoprophylaxis.
This was a retrospective observational cohort study of a level 1 trauma center from 9/2016 to 12/2018. All patients with trauma with rib fractures undergoing neuraxial blockade or ESPB were included. Demographics, chemoprophylaxis and anticoagulation regimens, outcomes, and complications were collected.
Nine hundred sixty-four patients with rib fracture(s) were admitted. Of these, 73 had a pain management consult. Thirteen had epidural catheters and 25 had ESPBs placed. There was no difference in demographics, injury patterns, bleeding complications, or venous thromboembolism rates among the groups. Patients with ESPB were less likely to have a dose of chemoprophylaxis held because of placement of a catheter (25% versus 100%, P < 0.00001). Three patients with ESPB were on oral anticoagulation on admission, and two were able to continue their regimen during placement.
ESPB can be safely placed in patients on chemoprophylaxis. It should be considered over traditional blocks in patients with blunt chest wall trauma because of its technical ease and ability to be performed with chemoprophylaxis.
目前针对严重肋骨骨折的指南建议在多模式疼痛治疗的基础上使用神经轴阻滞。虽然静脉血栓栓塞预防指南建议使用化学预防,但这些药物必须在放置神经轴阻滞时停用。竖脊肌平面阻滞(ESPB)是一种新描述的用于控制胸部疼痛的阻滞方法。其优点包括学习曲线快和潜在出血并发症少。我们描述了在接受化学预防的肋骨骨折患者中使用 ESPB 的情况。我们假设 ESPB 可以在不停止化学预防的情况下在该患者人群中进行。
这是一项回顾性观察性队列研究,对象是一家 1 级创伤中心,时间为 2016 年 9 月至 2018 年 12 月。所有接受过神经轴阻滞或 ESPB 治疗的创伤性肋骨骨折患者均纳入研究。收集人口统计学、化学预防和抗凝方案、结局和并发症等数据。
964 例肋骨骨折患者入院。其中 73 例接受了疼痛管理咨询。13 例患者有硬膜外导管,25 例患者进行了 ESPB 置管。三组患者在人口统计学、损伤模式、出血并发症或静脉血栓栓塞发生率方面无差异。由于放置导管,接受 ESPB 的患者更不可能停用化学预防药物(25%比 100%,P<0.00001)。3 例 ESPB 患者入院时正在服用口服抗凝药物,其中 2 例在置管期间能够继续服用。
ESPB 可安全用于接受化学预防的患者。对于钝性胸壁创伤患者,由于其技术简便和能够在接受化学预防的情况下进行,应考虑将其用于传统阻滞方法。